{
    "nct_id": "NCT06246357",
    "official_title": "Phase 2 Study Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism",
    "inclusion_criteria": "* INCLUSION CRITERIA:\n* Must have either of the following:\n\n  * one or more adrenal masses on CT and/or MRI with biochemical evidence of excess aldosterone or ACTH-independent hypercortisolism, OR\n  * history of ACTH-dependent hypercortisolism (with or without adrenal enlargement)\n* Co-enrollment in 19-DK-0066, 09-C-0242, 18-CH-0031 or a similar NIH trial.\n* Age >=18 years.\n* ECOG performance status <= 2.\n* Women of child-bearing potential (WOCBP) and men must agree to use an effective contraception (barrier, hormonal, intrauterine device [IUD], surgical sterilization, abstinence) for two weeks prior to [68Ga]Ga-PentixaFor scan and for one week after the [68Ga]Ga-PentixaFor scan.\n\n  * Breastfeeding should be discontinued for one week after the [68Ga]Ga-PentixaFor scan.\n  * Men must agree not to donate sperm for one week after the [68Ga]Ga-PentixaFor scan.\n* Participants must be able to understand and willing to sign a written informed consent document.\n\nEXCLUSION CRITERIA:\n\n* Positive beta-human chorionic gonadotropin (beta-HCG) serum or urine pregnancy test performed in females of childbearing potential at screening.\n* Uncontrolled intercurrent illness or social situations based on the review of medical history that would limit compliance with study requirements.\n* Contraindications to having an MRI and CT.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 120 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}